Paclitaxel liposome

DRUG7 trials

Conditions

Advanced Gastric CarcinomaAdvanced Pancreatic CancerChildrenEsophageal CancerEsophageal Squamous Cell CarcinomaNasopharyngeal CarcinomaSquamous Non-small-cell Lung Cancer

Phase 2

Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer

NCT02163291

Peking UniversityAdvanced Gastric Carcinoma

Start: 2013-12-31End: 2014-12-31Target: 30Updated: 2014-06-13

Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

NCT03020329

Sun Yat-sen UniversityChildren, Nasopharyngeal Carcinoma

Start: 2016-11-14End: 2022-12-30Target: 37Updated: 2019-08-07

SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

NCT03603756

Chinese Academy of Medical SciencesEsophageal Squamous Cell Carcinoma

Start: 2018-07-31End: 2021-03-28Target: 45Updated: 2020-02-11

Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma

NCT03668730

Sun Yat-sen UniversityNasopharyngeal Carcinoma

Start: 2018-10-19End: 2023-12-30Updated: 2021-08-24

Phase 3

Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer

WithdrawnNCT01998347

Shantou University Medical CollegeEsophageal Cancer

Start: 2013-11-30Updated: 2015-11-20

Phase 4

Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)

NCT02996214

Nanjing Luye Sike Pharmaceutical Co., Ltd.Squamous Non-small-cell Lung Cancer

Start: 2016-11-30End: 2020-06-30Target: 536Updated: 2020-02-13

Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients

NCT04217096

Fudan UniversityAdvanced Pancreatic Cancer

Start: 2020-01-01End: 2023-03-31Target: 40Updated: 2020-01-03

Related Papers

Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.

2023-09-0918 citations

Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial.

2023-08-317 citations

Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma

Cancer Communications2020-12-01134 citations

Phase 2 study of camrelizumab (anti-PD-1 antibody) combined with apatinib and chemotherapy for the first-line treatment of advanced esophageal squamous cell carcinoma.

Journal of Clinical Oncology2019-05-2012 citations